Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased susceptibility of this group highlights the urgent need for more effective preventive measures to mitigate risks and preserve kidney function. Background. This study aims to investigate the fundamental pathogenetic mechanisms contributing to the development of CIN and assess the effectiveness of various preventive interventions in patients with CAD and T2DM. Materials and Methods. The study was conducted in two distinct phases. The first phase involved a retrospective analysis of medical records from 56 patients who had undergone endovascular procedures involving contrast agents. The second phase included a prospective follow-up of 65 high-risk patients to evaluate preventive strategies.Clinical and laboratory indicators were meticulously analyzed, with a particular emphasis on tracking oxidative stress dynamics and endothelial function, which are considered pivotal in the pathogenesis of CIN. Results. The research led to the development of a novel risk assessment scale for predicting CIN occurrence. Preventive treatment with the antioxidant N-acetylcysteine (NAC) demonstrated a marked reduction in kidney damage rates, whereas the use of theophylline was found to be less effective. This highlights the superiority of antioxidant-based approaches in mitigating CIN risks. Conclusion. The findings underscore the efficacy of incorporating antioxidant therapies, particularly N-acetylcysteine, as a preventive measure for CIN in patients with coexisting cardiovascular and metabolic conditions. Implementing these strategies not only reduces the likelihood of renal complications but also improves the overall prognosis for this vulnerable population.
| Mualliflar | Муминов , Ш, Нигмонов, Б, Muminov , Shovkat, Nigmonov , Bakhodir, Muminov , Shovkat, Nigmonov , Bakhodir |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 3-13 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00001 |
DOI: 10.70626/cardiouz-2024-1-00001 · Maqolaning asl sahifasi
coronary artery disease, type 2 diabetes mellitus, contrast-induced acute kidney injury, prevention, oxidative stress, ишемическая болезнь сердца, сахарный диабет 2 типа, контраст-индуцированная нефропатия, профилактика, окислительный стресс, Yurak-tomir kasalliklari, 2-toifa shakar diabeti, oksidlovchi stress, kontrast-induksiya qilingan o'tkir buyrak shikastlanishi, profilaktika
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…
Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis…
Background. To study the characteristics of the clinical course of arterial hypertension by gender in the population of the Aral Sea region and to strengthen effective preventive measures. Materials and methods. The…
Background. Contrast-induced nephropathy (CIN) is a common complication among patients with ischemic heart disease (IHD) undergoing percutaneous coronary intervention (PCI). Understanding the pathogenesis, risk factors…